<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://functional.news/article/bioage-labs-announces-first-participant-dosed-in-quell-cv-a-phase-2-proof-of-con</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T12:00:00.000Z</news:publication_date>
      <news:title>BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/calidi-biotherapeutics-receives-positive-pre-ind-feedback-from-us-fda-for-cld-40</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T12:00:00.000Z</news:publication_date>
      <news:title>Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/through-the-muhc-foundation-one-family-helps-fuel-breakthrough-in-rare-cancer-re</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T12:00:00.000Z</news:publication_date>
      <news:title>Through the MUHC Foundation, one family helps fuel breakthrough in rare cancer research</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/une-famille-soutient-la-recherche-sur-les-cancers-rares-par-l-interm-diaire-de-l</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T12:00:00.000Z</news:publication_date>
      <news:title>Une famille soutient la recherche sur les cancers rares par l’intermédiaire de la Fondation du CUSM</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/le-king-faisal-specialist-hospital-pr-sente-la-chirurgie-robotique-comme-mod-le-</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T12:00:00.000Z</news:publication_date>
      <news:title>Le King Faisal Specialist Hospital présente la chirurgie robotique comme modèle de soins spécialisés axés sur l’innovation lors du congrès HLTH Europe 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/das-king-faisal-specialist-hospital-pr-sentiert-auf-der-hlth-europe-2026-die-rob</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T12:00:00.000Z</news:publication_date>
      <news:title>Das King Faisal Specialist Hospital präsentiert auf der HLTH Europe 2026 die Roboterchirurgie als Vorbild für innovationsgetriebene Spezialversorgung</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/king-faisal-specialist-hospital-presents-robotic-surgery-as-a-model-for-innovati</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T12:00:00.000Z</news:publication_date>
      <news:title>King Faisal Specialist Hospital Presents Robotic Surgery as a Model for Innovation-Driven Specialized Care at HLTH Europe 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/multivalent-biotherapies-launches-with-27-million-series-a-financing-to-advance-</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T12:00:00.000Z</news:publication_date>
      <news:title>MultiValent Biotherapies Launches with $27 Million Series A Financing to Advance Development of Targeted Prostate Cancer Drug Conjugate</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/recordati-celebrates-its-first-100-years-at-triennale-milano-with-an-exhibition-</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T11:16:00.000Z</news:publication_date>
      <news:title>RECORDATI CELEBRATES ITS FIRST 100 YEARS AT TRIENNALE MILANO WITH AN EXHIBITION REVEALING OBJECTS AND IMAGES FROM ITS HISTORICAL ARCHIVE FOR THE FIRST TIME</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/in-triennale-milano-recordati-celebra-i-suoi-primi-100-anni-con-una-mostra-che-s</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T11:16:00.000Z</news:publication_date>
      <news:title>IN TRIENNALE MILANO, RECORDATI CELEBRA I SUOI PRIMI 100 ANNI CON UNA MOSTRA CHE SVELA PER LA PRIMA VOLTA OGGETTI E IMMAGINI DEL SUO ARCHIVIO STORICO</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/vitalhub-announces-deployments-of-referral-management-solutions</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T11:00:00.000Z</news:publication_date>
      <news:title>VitalHub Announces Deployments of Referral Management Solutions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/ncap-medical-announces-publication-of-positive-rct-results-demonstrating-neurocu</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T11:00:00.000Z</news:publication_date>
      <news:title>nCAP Medical Announces Publication of Positive RCT Results Demonstrating NeuroCuple® Provides Meaningful, Opioid-Sparing Pain Relief Immediately Following Total Knee Arthroplasty</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/avalo-therapeutics-expands-pipeline-with-avtx-010-a-long-acting-next-generation-</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T11:00:00.000Z</news:publication_date>
      <news:title>Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/pasithea-therapeutics-announces-amendments-to-clinical-study-protocol-for-phase-</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T11:00:00.000Z</news:publication_date>
      <news:title>Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/l-occasion-du-congr-s-hlth-europe-2026-le-king-faisal-specialist-hospital-pr-sen</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T07:13:00.000Z</news:publication_date>
      <news:title>À l’occasion du congrès HLTH Europe 2026, le King Faisal Specialist Hospital présente son écosystème d’IA appliquée en radiologie</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/das-king-faisal-specialist-hospital-pr-sentiert-auf-der-hlth-europe-2026-sein-ko</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T07:13:00.000Z</news:publication_date>
      <news:title>Das King Faisal Specialist Hospital präsentiert auf der HLTH Europe 2026 sein Ökosystem für angewandte KI in der Radiologie</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/king-faisal-specialist-hospital-showcases-applied-ai-ecosystem-in-radiology-at-h</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T07:13:00.000Z</news:publication_date>
      <news:title>King Faisal Specialist Hospital Showcases Applied AI Ecosystem in Radiology at HLTH Europe 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/aplagon-announces-eur-5-million-financing-to-broaden-phase-2-trials-of-its-apac-</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T07:00:00.000Z</news:publication_date>
      <news:title>Aplagon Announces EUR 5 Million Financing to Broaden Phase 2 Trials of its APAC Therapy in Thrombo-Inflammatory Diseases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/alvotech-announces-pricing-of-152-million-public-offering-of-ordinary-shares-and</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T03:50:00.000Z</news:publication_date>
      <news:title>Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/alvotech-tilkynnir-um-ver-og-thlutun-hlutabr-fa-a-andvir-i-um-152-millj-nir-doll</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T03:50:00.000Z</news:publication_date>
      <news:title>Alvotech tilkynnir um verð og úthlutun hlutabréfa að andvirði um 152 milljónir dollara í útboði í Bandaríkjunum og lokuðu útboði til fagfjárfesta á Evrópska efnahagssvæðinu</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/lifeway-kefir-marks-40-years-with-soho-pop-up-on-national-kefir-day</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T23:30:00.000Z</news:publication_date>
      <news:title>Lifeway Kefir Marks 40 Years with SoHo Pop-Up on National Kefir Day</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/dignitas-wins-naic-the-root-brands-powers-pok-mon-unite-victory</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T21:53:00.000Z</news:publication_date>
      <news:title>Dignitas Wins NAIC: The ROOT Brands Powers Pokémon UNITE Victory</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/adaptive-biotechnologies-announces-plan-to-separate-its-mrd-and-immune-medicine-</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T20:10:00.000Z</news:publication_date>
      <news:title>Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/rhythm-pharmaceuticals-announces-multiple-new-data-presentations-from-mc4r-agoni</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T20:01:00.000Z</news:publication_date>
      <news:title>Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/alvotech-announces-proposed-125-million-public-offering-and-concurrent-private-p</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T20:01:00.000Z</news:publication_date>
      <news:title>Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/alvotech-efnir-til-tbo-s-hlutabr-fum-bandar-kjunum-a-andvir-i-125-millj-nir-doll</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T20:01:00.000Z</news:publication_date>
      <news:title>Alvotech efnir til útboðs á hlutabréfum í Bandaríkjunum að andvirði 125 milljónir dollara samhliða lokuðu útboði til fagfjárfesta á Evrópska efnahagssvæðinu</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/ethy-001-shows-complete-tshr-blockade-in-graves-disease-preclinical-data</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T18:45:00.000Z</news:publication_date>
      <news:title>ETHY-001 Shows Complete TSHR Blockade in Graves&apos; Disease Preclinical Data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/editor-s-note-submitted-release-outside-functional-news-coverage-scope-671912</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T17:26:00.000Z</news:publication_date>
      <news:title>Editor&apos;s Note: Submitted Release Outside Functional News Coverage Scope</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/peanuts-linked-to-brain-health-benefits-via-nutrient-density</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T16:39:00.000Z</news:publication_date>
      <news:title>Peanuts Linked to Brain Health Benefits via Nutrient Density</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/rivox-labs-debuts-nicotine-free-focus-pouches-and-energy-gum</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T16:23:00.000Z</news:publication_date>
      <news:title>Rivox Labs Debuts Nicotine-Free Focus Pouches and Energy Gum</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/editor-s-note-no-functional-foods-story-found-in-source</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T15:04:00.000Z</news:publication_date>
      <news:title>Editor&apos;s Note: No Functional Foods Story Found in Source</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/kfsh-spotlights-health-system-innovation-at-hlth-europe-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T15:00:00.000Z</news:publication_date>
      <news:title>KFSH Spotlights Health-System Innovation at HLTH Europe 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/off-topic-submission-no-functional-ingredient-news-to-report-7aa5ea</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T15:00:00.000Z</news:publication_date>
      <news:title>Off-Topic Submission: No Functional Ingredient News to Report</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/press-release-outside-functional-foods-scope-no-rewrite-possible</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T15:00:00.000Z</news:publication_date>
      <news:title>Press Release Outside Functional Foods Scope: No Rewrite Possible</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/pharmacist-otc-survey-flags-preferred-brands-across-145-categories</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T15:00:00.000Z</news:publication_date>
      <news:title>Pharmacist OTC Survey Flags Preferred Brands Across 145 Categories</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/bcc-research-ai-becomes-strategic-necessity-in-bispecific-antibody-dev</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T14:54:00.000Z</news:publication_date>
      <news:title>BCC Research: AI Becomes Strategic Necessity in Bispecific Antibody Dev</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/france-biotech-brings-healthtech-delegation-to-bio-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T14:45:00.000Z</news:publication_date>
      <news:title>France Biotech Brings HealthTech Delegation to BIO 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/off-topic-submission-no-functional-food-content-to-process</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T14:38:00.000Z</news:publication_date>
      <news:title>Off-Topic Submission: No Functional Food Content to Process</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/adc-drug-conjugate-market-hits-42-55b-forecast-by-2035</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T14:30:00.000Z</news:publication_date>
      <news:title>ADC Drug Conjugate Market Hits $42.55B Forecast by 2035</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/summer-fresh-launches-11-recipe-booklet-for-seasonal-retail-push</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T14:00:00.000Z</news:publication_date>
      <news:title>Summer Fresh Launches 11-Recipe Booklet for Seasonal Retail Push</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/cardiawave-launches-valvosoft-treatments-post-ce-mark-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T14:00:00.000Z</news:publication_date>
      <news:title>Cardiawave Launches Valvosoft Treatments Post-CE Mark Approval</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/betterbrand-targets-wildfire-smoke-exposure-with-respiratory-supplement</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T14:00:00.000Z</news:publication_date>
      <news:title>Betterbrand Targets Wildfire Smoke Exposure With Respiratory Supplement</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/neuroplasticity-pioneer-merzenich-wins-merkin-prize-for-cochlear-work</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T14:00:00.000Z</news:publication_date>
      <news:title>Neuroplasticity Pioneer Merzenich Wins Merkin Prize for Cochlear Work</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/off-topic-submission-cannot-be-rewritten-as-functional-news</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T13:48:00.000Z</news:publication_date>
      <news:title>Off-Topic Submission Cannot Be Rewritten as Functional News</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/prosomnus-monitair-link-oat-device-data-to-remote-osa-monitoring</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T13:00:00.000Z</news:publication_date>
      <news:title>ProSomnus, MonitAir Link OAT Device Data to Remote OSA Monitoring</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/xbiotech-s-vilamakitug-enters-phase-ii-trial-for-axial-spa</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T13:00:00.000Z</news:publication_date>
      <news:title>XBiotech&apos;s Vilamakitug Enters Phase II Trial for Axial SpA</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/xbiotech-s-vilamakitug-clears-fda-ind-review-for-phase-ii-axial-spa-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T13:00:00.000Z</news:publication_date>
      <news:title>XBiotech&apos;s Vilamakitug Clears FDA IND Review for Phase II Axial SpA Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/xbiotech-s-vilamakitug-clears-fda-ind-review-for-phase-ii-axspa-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T13:00:00.000Z</news:publication_date>
      <news:title>XBiotech&apos;s Vilamakitug Clears FDA IND Review for Phase II AxSpA Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/off-topic-submission-no-functional-ingredient-or-nutraceutical-found-aad337</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T13:00:00.000Z</news:publication_date>
      <news:title>Off-Topic Submission: No Functional Ingredient or Nutraceutical Found</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://functional.news/article/cocogoodsco-launches-6g-prebiotic-fiber-coconut-water-sku</loc>
    <news:news>
      <news:publication>
        <news:name>Functional News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T13:00:00.000Z</news:publication_date>
      <news:title>CocoGoodsCo Launches 6g Prebiotic Fiber Coconut Water SKU</news:title>
    </news:news>
  </url>
</urlset>